VONTOBEL HLDG N (VTLN MU) stock market data APIs
€64.9359
0(0%)
as of September 18, 2025
Try our APIs with
free plan!
VONTOBEL HLDG N Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for VTLN.MU.
Prev. Close
64.9359
Open
64.9359
High
64.9359
Low
64.9359
52 wk Range
45.6581-74.2
Market Cap
4 252 M
Dividends (Yield)
0.0614
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get VONTOBEL HLDG N data using free add-ons & libraries
Get VONTOBEL HLDG N Fundamental Data
VONTOBEL HLDG N Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
VONTOBEL HLDG N News
New
Health Care Roundup: Market Talk
0809 GMT – Novartis’s $1.4 billion deal to buy Tourmaline Bio looks like a strategically meaningful move that is set to complement its cardiovascular-treatment pipeline, Vontobel analyst Stefan Sc...
Vontobel Holding AG (VTX:VONN) has caught the attention of institutional investors who hold a sizeable 39% stake
Key Insights Significantly high institutional ownership implies Vontobel Holding's stock price is sensitive to their trading actions The top 6 shareholders own 54% of the company Using data from anal...
Explainer-Nestle's new CEO faces full plate of problems
By Paolo Laudani (Reuters) -The abrupt dismissal of Nestle CEO Laurent Freixe has catapulted Philipp Navratil into the top job overnight, tasking him with reversing a prolonged share price decline an...
Health Care Roundup: Market Talk
Find insight on Swiss pharma stocks, European pharma companies and more in the latest Market Talks covering Health Care. Continue Reading View Comments
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
